Skip to main content
. 2022 Feb 26;32(5):e2336. doi: 10.1002/rmv.2336

FIGURE 2.

FIGURE 2

Network of eligible comparisons for respiratory viruses. (a) Influenza virus. (b) Coronavirus (including SARS, MERS and COVID‐19). (c) SARS (SARS‐CoV) and MERS (MERS‐CoV). (d) COVID‐19 (SARS‐CoV‐2). Control includes no mask wearing, or mask wearing at very low frequencies. Non‐medical masks include clothes or cotton masks. Lines indicate direct comparisons of agents, and the thickness of line corresponds to the number of trials in the comparison. The size of node corresponds to the number of studies that involve the intervention. COVID‐19, coronavirus disease‐19; MERS, Middle East respiratory syndrome; SARS, severe acute respiratory syndrome